wearable device aimed at tackling Tourettes Syndrome (TS)
Neupulse has raised €3.5M across 2 funding rounds from 2 investors, most recently a round in Aug 2024. Based in Nottingham, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-08-01 | Other | €593k | Midlands Engine Investment Fund II | View deal → |
| 2024-03-18 | Seed | €2.9M | Eos Advisory | View deal → |
